
George Delgado, M.D., F.A.A.F.P.
Guest ContributorDr. George Delgado is the president of Steno Institute, a nonprofit research institute established in 2018 with a goal of furthering research, education, and awareness around abortion pill reversal. Dr. Delgado was one of the pioneers of abortion pill reversal and established the Abortion Pill Reversal network in 2012. He has authored or co-authored four articles in peer-reviewed medical journals regarding abortion pill reversal and mifepristone abortion. Additionally, he is the medical director of Culture of Life Family Services in San Diego County, where he practices family medicine.
Dr. Delgado received his medical degree from UC Davis and completed his residency at Santa Monica Hospital/UCLA. He is board-certified in family medicine and in hospice and palliative medicine. Dr. Delgado completed the one-year certification program in health care ethics offered by the National Catholic Bioethics Center. He has been a member of the American Association of Pro-Life Obstetricians and Gynecologists board of directors since 2012.
Dr. Delgado was selected to receive the St. Gianna Molla Pro-Life Award at the 2017 Walk for Life West Coast. In April 2018, Heartbeat International awarded him a Servant Leader Award. Solidarity HealthShare granted him its Pro-Life Innovator Award in January 2019, on the eve of the March for Life in Washington, DC. In 2021, Heartbeat International granted him the Legacy Award. The Catholic Medical Association presented him with the Evangelium Vitae Award at its annual conference in 2021. In 2025, he received the Life Award from Live Action. In June 2026, National Right to Life will grant him the Proudly Pro-Life Award; previous awardees include St. John Paul II, St. Teresa of Kolkata, and Dr. James Dobson.
Dr. Delgado authored Abortion Pill Reversal: A Second Chance at Choice, published by Ignatius Press in 2025. It is written for general audiences.
Research Authored
Written Testimony of George Delgado, M.D., F.A.A.F.P., in Support of Colorado Abortion Pill Reversal Bill
On Thursday, February 9, 2017, the Colorado House Health, Insurance and Environment Committee held a hearing regarding House Bill 1086 (HB 1086), the Abortion Pill Reversal Information Act. HB 1086 provides that prior to initiating a chemical abortion, a physician must alert the woman to the fact that it may be possible to reverse the abortion should she change her mind and that information on the possibility of reversal is available in state-prepared materials.
